New York Non-Local Sources NY

Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease

Daily Mail on New York

Oct 6, 2020

Oct 6 (Reuters) - U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic...

Read the full story at Daily Mail on New York

Topics

#Biogen

Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease

Topics

More from New York Non-Local Sources

Surveillance video shows NYC terror suspect buying fireworks fuse in Pennsylvania

Hero NYPD officers honored for foiling alleged ISIS-inspired terror plot near Gracie Mansion

Mamdani sparks viral outrage over dinner photo with Mahmoud Khalil inside Gracie Mansion: 'Disgraceful'

Alexander brothers learn fate in federal sex trafficking trial

Officials confirm devices recovered at NYC protest near Gracie Mansion were both IEDs

Video captures chaos erupting at NYC vigil for slain Ayatollah Khamenei as punches fly

Former New York D.A.R.E. officer admits to selling drugs while in uniform in squad car

Supreme Court sides with New York Republican in congressional redistricting fight

Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig&#39;s disease

Topics

More from New York Non-Local Sources

Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease